Watch VideoPfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.
Currently all COVID-19 treatments used in the U.S. require an IV or...
Pfizer COVID-19 Pill Reduced Deaths, Hospitalizations by 89%
Newsy
0 shares
1 views
You might like
Related news coverage
FDA Reviewing Merck's COVID Pill For Emergency Authorization
Newsy
Watch VideoAn experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one..
Advertisement
More coverage
Pfizer, U.S. ink $5.29B deal for COVID pill
PIX 11
NEW YORK (AP) — The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential..
-
State Leaders Push For Booster Expansion Despite Federal Guidance
Newsy
-
Pfizer seeks US emergency authorization for COVID-19 pill
Deutsche Welle
-
Pfizer asks US officials to OK promising COVID-19 pill
SeattlePI.com
-
Alert: Pfizer asks US regulators to authorize COVID-19 pill that reduces deaths, hospitalizations
SeattlePI.com